127 related articles for article (PubMed ID: 3127325)
1. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
[TBL] [Abstract][Full Text] [Related]
2. Pertussigen in vivo enhances antigen-specific production in vitro of lymphokine that stimulates macrophage procoagulant activity and plasminogen activator.
de Moerloose PA; Hamilton JA; Sewell WA; Vadas MA; Mackay IR
J Immunol; 1986 Dec; 137(11):3528-33. PubMed ID: 3782790
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
Sewell WA; Munoz JJ; Scollay R; Vadas MA
J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.
Mu HH; Sewell WA
Immunology; 1994 Dec; 83(4):639-45. PubMed ID: 7875744
[TBL] [Abstract][Full Text] [Related]
5. Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.
Sewell WA; de Moerloose PA; McKimm-Breschkin JL; Vadas MA
Cell Immunol; 1986 Feb; 97(2):238-47. PubMed ID: 3091271
[TBL] [Abstract][Full Text] [Related]
6. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness.
Hoyne GF; Callow MG; Kuhlman J; Thomas WR
Immunology; 1993 Apr; 78(4):534-40. PubMed ID: 8495970
[TBL] [Abstract][Full Text] [Related]
7. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
Ulrich P; Vohr HW
Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity responses in mice treated with pertussis toxin and betamethasone.
Torre D; Pugliese A; Quadrelli C; Maggiolo F
Boll Ist Sieroter Milan; 1988; 67(2):123-7. PubMed ID: 3228495
[TBL] [Abstract][Full Text] [Related]
9. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
[TBL] [Abstract][Full Text] [Related]
10. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
Thomson JA; Troutt AB; Kelso A
Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
Issekutz TB; Stoltz JM; vd Meide P
J Immunol; 1988 May; 140(9):2989-93. PubMed ID: 3129506
[TBL] [Abstract][Full Text] [Related]
12. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.
Sewell WA; Munoz JJ; Vadas MA
J Exp Med; 1983 Jun; 157(6):2087-96. PubMed ID: 6304228
[TBL] [Abstract][Full Text] [Related]
14. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
15. Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12.
Tsung K; Meko JB; Tsung YL; Peplinski GR; Norton JA
J Immunol; 1998 Feb; 160(3):1369-77. PubMed ID: 9570556
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.
Brooks JC; Hoskin DW
Transplantation; 1994 Nov; 58(10):1096-103. PubMed ID: 7974716
[TBL] [Abstract][Full Text] [Related]
17. [Immunopotentiation of novel adjuvant SWZY on the poorly immunogenic murine melanoma vaccine].
Zhou Y; Qi X; Xiao JX; Lai BC; Si LS; Wang YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):526-9. PubMed ID: 16806024
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: functional roles of interleukin-5-producing CD4(+) lymphocytes.
Sasaki G; Satoh T; Yokozeki H; Katayama I; Nishioka K
Cell Immunol; 2000 Aug; 203(2):124-33. PubMed ID: 11006010
[TBL] [Abstract][Full Text] [Related]
19. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
[TBL] [Abstract][Full Text] [Related]
20. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.
Dieli F; Asherson GL; Romano GC; Sireci G; Gervasi F; Salerno A
J Immunol; 1994 Mar; 152(6):2698-704. PubMed ID: 8144876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
